Trial results also showed that after three months, individuals taking benralizumab were four times less likely to experience an asthma or COPD attack compared to those on the steroid prednisolone.

Do inhaled corticosteroids elevate risk for pneumonia in patients with chronic obstructive pulmonary disease? Several clinical trials, observational studies, and meta-analyses suggest that they do ...